Article Versions Notes

Shen Y, Nussbaum YI, Manjunath Y, Hummel JJ, Ciorba MA, Warren WC, Kaifi JT, Papageorgiou C, Cortese R, Shyu C-R, et al. TBX21 Methylation as a Potential Regulator of Immune Suppression in CMS1 Subtype Colorectal Cancer. Cancers. 2022; 14(19):4594. https://doi.org/10.3390/cancers14194594

Shen, Yuanyuan, Yulia I. Nussbaum, Yariswamy Manjunath, Justin J. Hummel, Matthew A. Ciorba, Wesley C. Warren, Jussuf T. Kaifi, Christos Papageorgiou, Rene Cortese, Chi-Ren Shyu, and et al. 2022. "TBX21 Methylation as a Potential Regulator of Immune Suppression in CMS1 Subtype Colorectal Cancer" Cancers 14, no. 19: 4594. https://doi.org/10.3390/cancers14194594

Shen, Y., Nussbaum, Y. I., Manjunath, Y., Hummel, J. J., Ciorba, M. A., Warren, W. C., Kaifi, J. T., Papageorgiou, C., Cortese, R., Shyu, C.-R., & Mitchem, J. B. (2022). TBX21 Methylation as a Potential Regulator of Immune Suppression in CMS1 Subtype Colorectal Cancer. Cancers, 14(19), 4594. https://doi.org/10.3390/cancers14194594